Altimmune ALT Proceeds From Issuance Of Common Stock And Pre Funded Warrants Direct Offering Net
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept alt:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsDirectOfferingNet.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's proceeds from issuance of common stock and pre funded warrants direct offering net.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's proceeds from issuance of common stock and pre funded warrants direct offering net?
- Altimmune (ALT) reported proceeds from issuance of common stock and pre funded warrants direct offering net of $70.34M in Q1 2026.